Barry Sharaf, MD
Interventional Cardiology · Providence, RINPI 1255352738
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Edwards Lifesciences at 52.9% of the total. Reporting peaked in 2022 at $955 and has fallen 52.9% since, to $450 in 2025. That places this record below the midpoint for interventional cardiology clinicians in RI, where the typical reported total is $3,343.
Across 61 payments — averaging $45.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$1K
- Shockwave Medical, Inc$648
- Medtronic$492
- Teleflex LLC$130
- Abbott$51
What the payments were for
- Food & beverage$2,804100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 37 | $1,482 |
| Shockwave Medical, Inc | 4 | $648 |
| Medtronic(2 entities) | 17 | $492 |
| Teleflex LLC | 1 | $130 |
| Abbott | 2 | $51 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,804 in reported general payments places this provider in the 45th percentile of 23 interventional cardiology providers in Rhode Island.
See all interventional cardiology providers in Rhode Island →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 44 | $39,571 |
| BrilintaTicagrelor | 36 | $31,336 |
| XareltoRivaroxaban | 14 | $21,218 |
| Rosuvastatin Calcium | 79 | $2,402 |
| ClopidogrelClopidogrel Bisulfate | 164 | $2,179 |
| Atorvastatin Calcium | 175 | $1,920 |
| Metoprolol Tartrate | 156 | $1,376 |
| Metoprolol Succinate | 81 | $1,175 |
| Ezetimibe | 27 | $839 |
| Lisinopril | 78 | $761 |
| Prasugrel Hcl | 12 | $732 |
| Losartan Potassium | 53 | $478 |
| Nitroglycerin | 26 | $395 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 20 | $393 |
| Atenolol | 25 | $275 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Providence
- Peter SoukasProvidence$798K
- Jinnette AbbottProvidence$156K
- Marwan SaadProvidence$57K
- Hafiz ImranProvidence$18K
- Paul GordonProvidence$13K
- Omar HyderProvidence$9K
- Anum AsifProvidence$6K
- Ahmed ElkaryoniProvidence$3K
- Mitchel SklarProvidence$2K
- Saraschandra VallabhajosyulaProvidence$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.